Upcoming Webinars

Advances in Ocular Melanoma

Wednesday, 22 April 2026 | 7:00 – 8:30 p.m. ET

This webinar provides a practical overview of ocular melanoma, including key concepts in diagnosis and treatment as cases become more frequently recognized in clinical practice. Faculty will review the management of uveal melanoma, with a focus on percutaneous hepatic perfusion (PHP), and discuss immunoembolization approaches for treating melanoma metastases to the liver.

Faculty

Moderator

headshot

Venkatesh Krishnasamy, MD

University of Alabama, Birmingham

Faculty

Robert Adamo, MD

Robert Adamo, MD

Thomas Jefferson University

Shaheer Khan, DO

Shaheer Khan, DO

Northwell Health

Eric Wehrenberg-Klee, MD

Eric Wehrenberg-Klee, MD

Harvard University

Register Now

This webinar is sponsored by:

Delcath
 

Thoracic Diseases: Learning from Our Own, Helping Others, and Knowing When to Walk Away

Wednesday, 29 April 2026 | 7:00 – 8:30 p.m. ET

This webinar examines real-world complications in thoracic interventional oncology, drawing practical lessons from lung ablation and patient management. Faculty will review strategies to prevent and manage complications related to lung biopsy and lung tumor ablation, including insights on what they would approach differently in hindsight. Attendees will also explore clinical scenarios where thoracic interventional oncology can help optimize outcomes for patients who are not ideal candidates for surgery or radiation therapy.

Faculty

Florian J. Fintlemann, MD

Florian J. Fintlemann, MD

Harvard University

DaeHee Kim

DaeHee Kim, MD

Brown University

Robert Short, MD

Robert Short, MD

Dayton VA Medical Center

Register Now

This webinar is sponsored by:

Johnson & Johnson
 

Hepatobiliary Diseases: Learning From Our Own, Rescuing Others, and Knowing When to Walk Away

Wednesday, 20 May 2026 | 7:00 – 8:30 p.m. ET

This webinar provides a practical overview of recognizing and managing complications in liver cancer locoregional therapy. Faculty will discuss how treatment modality, tumor biology, and patient physiology contribute to predictable risks; how to distinguish benign post‑treatment syndromes from true complications requiring intervention; and how interventional oncology can address issues arising from upstream diagnostic or therapeutic decisions.

Faculty

Robert Adamo, MD

Nima Kokabi, MD

University of North Carolina

Shaheer Khan, DO

Daniel DePietro, MD

University of Pennsylvania 

Eric Wehrenberg-Klee, MD

Shamar Young, MD

University of Arizona

Register Now

 

Missed a Session?

Catch up anytime — previous webinars in this series are available on our on-demand page.

View On-Demand Webinars